930 results

• EU Launches Investigation Into Ozempic Vision Loss Problems

  December 23, 2024

  Irvin Jackson

  Following nearly 20 reports of vision problems from Ozempic or Wegovy since a study was published in July 2024, Danish health officials are calling for an EU investigation into the safety of semaglutide-based drugs.

• Ozempic NAION Vision Loss Risks Confirmed in Another Study

  December 16, 2024

  Irvin Jackson

  A Danish study warns that using Ozempic and Wegovy could double the risk of a condition known to cause vision changes and blindness.

• MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025

  December 5, 2024

  Irvin Jackson

  With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.

• Ozempic Ileus Lawsuit Filed by Woman Left With Gastrointestinal Problems After Receiving Injections for 2 Years

  November 25, 2024

  Irvin Jackson

  Alabama woman is seeking both compensatory and punitive damages, claiming she suffered multiple gastrointestinal problems due to the side effects of the Novo Nordisk diabetes drug, Ozempic.

• Ozempic Side Effects May Shrink Heart Muscles, Study Warns

  November 20, 2024

  Irvin Jackson

  Canadian researchers warn that side effects of Ozempic, Wegovy and other similar drugs may cause the heart muscles to atrophy, making it more difficult for users to exercise.

• Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL

  November 15, 2024

  Irvin Jackson

  Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

• Infant PFAS Exposure Linked to Cholesterol and Weight Problems, Study Warns

  November 13, 2024

  Irvin Jackson

  A new study suggests that PFAS exposure in utero could increase the risk of hypertension, diabetes and other metabolic disorders in newborns.

• Pulmonary Aspiration Warning Added to Ozempic, Wegovy, Mounjaro and Other GLP-1s Regarding Use Before Anesthesia or Deep Sedation

  November 7, 2024

  Irvin Jackson

  The FDA is requiring new label warnings for Ozempic, Wegovy, Mounjaro and all other GLP-1 drugs, indicating they may cause pulmonary aspiration during surgery.

• Evidence Linking Ozempic and Gastroparesis, Ileus, Other Injuries Will Be Addressed In Early MDL Discovery

  October 31, 2024

  Irvin Jackson

  Early discovery in the federal GLP-1 litigation will include an examination of general causation evidence before individual Ozempic lawsuits are prepared for bellwether trials.

• Certain Birth Control Pills Linked to Diabetes Risk and Blood Sugar Regulation Issues: Study

  October 30, 2024

  Michael Adams

  Studies indicate women have seen an increased risk of heart disease, stroke and type 2 diabetes in recent decades, although researchers have not previously looked into how the increasing usage of birth control pills in recent decades may be affecting these conditions.